ARCHIVES

Phase III Study: Lymphoseek Superior to Vital Blue Dye

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

Samuel Broder Plans To Leave Celera.

September 10, 2010

NCI relaxes Core Grants Support For Clinical Trials Research

December 11, 1992

NCI declined to pay for economic, quality of life analysis in Avastin, Erbitux study.

June 3, 2005

Reauthorization Bill Ready For Senate Floor; Report to Panel Makes Clear Why Renewal Needed

April 22, 1988

Senate Subcommittee Adds $98 Million to NCI’s FY 1984 Budget, Assuring Substantial Increase

September 30, 1983

Finasteride Does Not Affect Quality of Life, Says Study

September 28, 2012